Analysis of Some Demographic, Hematological, and Immunological Parameters among Chronic Hepatitis B Patients with Coronary Artery Disease in Iraq
DOI:
https://doi.org/10.36330/kmj.v21.i2.20875Keywords:
caspase -9, HBV, CardiovascularAbstract
Background: Hepatitis B is a major global health problem. It is an infection of the liver caused by the hepatitis B virus. The infection can be acute or chronic. Purpose: To assess and compare demographic, hematological, and immunological parameters among chronic hepatitis B patients and identify significant clinical patterns and associations. Methods: A cross-sectional study of 200 hepatitis B patients with coronary artery disease (117males, 83 females) was conducted at Al-Sader Teaching Hospital, Najaf, from November 1, 2023, to December 1, 2024. Serum Blood samples were analyzed for hematological and immunological parameters were measured using ELISA. Results: Among 200 patients, most were from Al-Najaf (75.5%). Unstable angina was most common (35.5%). Males showed higher hematological values than females, including lymphocytes ( p=0.008), RBC (p=0.003), PLT (p=0.006), HB (p<0.001), and WBCs (p=0.002). Diabetic patients had reduced lymphocytes, PLT, HB, and WBCs (all p<0.05) and elevated RBC (p<0.001). Caspase-3 and -9 were significantly higher in asthma, TB, and bronchial allergies compared to those without comorbidities (p<0.001). Smokers had higher caspase-3 (14.2±3.5 vs. 8.9±2.8, p=0.008) and caspase-9 (28.6±4.2 vs. 19.3±3.6, p<0.001) than non-smokers. Conclusion: Chronic hepatitis B in Iraqi patients with coronary artery disease predominantly manifests as unstable angina, with hematological and immunological changes, especially elevated apoptotic markers determined by sex, diabetes, blood group, comorbidities, and smoking. These findings underscore the importance of integrated monitoring and targeted management strategies in this population.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Rana Al-Nafakh

This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the KMJ website, given that KMJ is responsible to appreciate citation for their work, which is released under CC-BY-4.0 enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.









